Скачать или смотреть Asia-Pacific Scientists Unite to Create Pan-Cancer Atlas with 10x Genomics' Xenium

An exciting new initiative, the Asia-Pacific Spatial Translational Research Alliance (ASTRA), brings together researchers from Australia and Japan to create a comprehensive pan-cancer spatial atlas. Led by the Garvan Institute and the University of Tokyo, ASTRA aims to map cancer and immune cell interactions across 2,000 tumor samples using 10x Genomics' cutting-edge Xenium spatial platform. This project will revolutionize precision oncology in the region by providing a shared foundation for cancer research and treatment, addressing the unique cellular context and genetic diversity of Asian populations.
The consortium will study ten major cancer types, integrating molecular and spatial data to identify immune interactions and molecular features specific to the Asia-Pacific region. By doing so, ASTRA will contribute to the development of personalized medicine and ensure that cancer treatments are tailored to the diverse needs of patients in the region. The project's initial collaboration between Australia and Japan will expand to include other Asia-Pacific countries, fostering international cooperation and addressing logistical challenges in biospecimen movement and data harmonization.
ASTRA represents a significant step towards global equity in cancer research, ensuring that the cellular complexity of cancer in Asian populations is accurately represented and understood. With the support of the ASPIRE program and the use of advanced spatial biology technology, ASTRA is poised to make groundbreaking contributions to the field of oncology and improve healthcare outcomes for patients across the Asia-Pacific.